Allarta to present at the 2025 Cell & Gene Meeting on the Med in Rome, Italy

We’re thrilled to announce that Dr. Harald Stover, Founder and CEO of Allarta Life Science, will present and participate as a panelist at the upcoming Cell & Gene Meeting on the Med in Rome, Italy on April 16th.

Allarta is excited to showcase our latest advancements aimed at enabling the global scale-up and delivery of allogeneic cell-based therapies for chronic endocrine disorders and other conditions.

Our custom hydrogels and materials feature uniquely tunable permeability that can be tailored for various therapeutic modalities. With immuno-protective and retrievable capabilities, our materials allow for the delivery of allogeneic cell therapies without the need for systemic immune suppression. This will provide significant benefits to patients with inflammatory and metabolic disorders, including diabetes.

Additionally, Allarta develops proprietary cryoprotective gels that prevent cell aggregation and minimize ice crystal formation, ensuring the safe delivery of high-value cell payloads at scale. This novel technology facilitates the safe transportation and cryostorage of therapeutic cell products.

Our industry-leading technology platform, combined with innovative transportation and storage solutions, will help accelerate the transition from conceptual ideas to globally competitive products in the industry.

 

Company Presentations

Salone dei Cavalieri, Section 2
Day 2 – April 16, 2025
10:45am – 12:15pm

Dr. Harald Stover presents at 11:00am.

 

Panel Discussion

Diabetes – Cell and Tissue Therapy Approaches to Provide Durable Solutions

Salone dei Cavalieri, Section 3 & 4
Day 2 – April 16, 2025
1:45pm–2:45pm

Moderator:

  • Eytan Abraham, Ph.D., Chief Commercial and Technology Officer, Minaris Regenerative Medicine

Panelists:

  • Bernd Muehlenweg, Ph.D., Senior Vice President, Head of Global Business Development, Cell Therapy, Evotec; Non-Executive Director, Sernova
  • Vlad Seitan, Ph.D., Chief Scientific Officer, Laverock Therapeutics
  • Harald Stover, Ph.D., Founder and CEO, Allarta Life Science; Professor of Chemistry and Chemical Biology, McMaster University